SaferMedsNL Phase Two, deprescribing for sedatives, begins today, Monday, February 3, 2020 and runs until February 3, 2021.
SaferMedsNL is a three-year universal program, open to all residents - not just those under NLPDP. As previously announced, Phase One – deprescribing of PPIs – has been extended for one year and will continue along with Phase Two – deprescribing of sedatives – until February 3, 2021.
Important policy changes
PANL is pleased to advise that based on your input and feedback, the Department of Health and Community Services has agreed to adjust the follow up criteria as follows. Please note that these changes apply to Phase One and Phase Two.
- Pharmacists will be allowed to follow up with patients independent of the physician responding to the Pharmaceutical Opinion form or changing the prescription. This is a $10 billable activity
- The requirement to fax the Pharmaceutical Opinion form to physicians if the patient is not a candidate for deprescribing has been removed.
Phase Two Resources are Available on the PANL website: www.panl.net. These include:
- Sedatives Pharmaceutical Opinion Form
- Phase Two Policy Procedure Document
- Empower Brochure
- Sleep Brochure
Pharmacists are encouraged to visit https://safermedsnl.ca/sleeping-pills-resources for further information and to access a range of helpful tools and resources available to both healthcare providers and patients to promote positive change around medication use.
The Pharmacists' Association of NL
85 Thorburn Road, Suite 203
St. John's, NL A1B 3M2